🇺🇸 FDA
Patent

US 7572828

Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid

granted A61KA61K31/194A61K31/29

Quick answer

US patent 7572828 (Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/194, A61K31/29, A61K45/06, A61P